FDA — authorised 6 July 1949
- Marketing authorisation holder: RANBAXY
- Status: approved
🇺🇸 Eurax in United States
FDA authorised Eurax on 6 July 1949
Marketing authorisations
FDA — authorised 6 July 1949
- Application: NDA006927
- Marketing authorisation holder: JOURNEY
- Local brand name: EURAX
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 29 April 1955
- Application: NDA009112
- Marketing authorisation holder: JOURNEY
- Local brand name: EURAX
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 16 December 1981
- Application: ANDA087204
- Marketing authorisation holder: LEGACY PHARMA
- Local brand name: CROTAN
- Indication: LOTION — TOPICAL
- Status: approved
Eurax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in United States
Frequently asked questions
Is Eurax approved in United States?
Yes. FDA authorised it on 6 July 1949; FDA authorised it on 6 July 1949; FDA authorised it on 29 April 1955.
Who is the marketing authorisation holder for Eurax in United States?
RANBAXY holds the US marketing authorisation.